about
Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patientsStem cell therapy with skeletal myoblasts accelerates neointima formation in a mouse model of vein graft disease.Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts.Enhanced cell therapy for ischemic heart disease.Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats.Sparing the aortic root in acute aortic dissection type A: risk reduction and restored integrity of the untouched root.Acute type A dissection in octogenarians: does emergency surgery impact in-hospital outcome or long-term survival?Impact of cold ischemia on mitochondrial function in porcine hearts and blood vesselsThe amounts of alpha 1 antitrypsin protein are reduced in the vascular wall of the acutely dissected human ascending aorta.Is the axillary artery a suitable cannulation site in aortic surgery?Type A aortic dissection after nonaortic cardiac surgery.Surgical problems and complex procedures: issues for operative time in robotic totally endoscopic coronary artery bypass grafting.Robotic totally endoscopic coronary artery bypass: program development and learning curve issues.Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts.Predictors and consequences of postoperative atrial fibrillation following robotic totally endoscopic coronary bypass surgery.Factors associated with presence of ascending aortic atherosclerosis in CABG patients.Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts.Prediction of paravalvular regurgitation after transcatheter aortic valve implantation by computed tomography: value of aortic valve and annular calcification.Neointimal Hyperplasia in Coronary Vein Grafts: Pathophysiology and Prevention of a Significant Clinical Problem.Aortic dissection type A in alpine skiers.Distal leg protection for peripheral cannulation in minimally invasive and totally endoscopic cardiac surgery.Treatment of double vessel coronary artery disease by totally endoscopic bypass surgery and drug-eluting stent placement in one simultaneous hybrid session.The influence of ascending aortic atherosclerosis on the long-term survival after CABG.High-resolution 16-MDCT evaluation of radial artery for potential use as coronary artery bypass graft: a feasibility study.Robotically assisted hybrid coronary revascularization: does sequence of intervention matter?Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart.Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure.Evaluation of left ventricular function by 64-multidetector computed tomography in patients undergoing totally endoscopic coronary artery bypass grafting.How to improve performance of robotic totally endoscopic coronary artery bypass grafting.In DeBakey Type I Aortic Dissection, Bovine Aortic Arch Is Associated With Arch Tears and Stroke.Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts.Patent foramen ovale and major pulmonary embolism.Hot potatoes, million dollar coat hangers and advanced coronary surgery.Long-Term Clinical and Computed Tomography Angiographic Follow-up After Totally Endoscopic Coronary Artery Bypass Grafting.Does preoperative multislice computed tomography predict operative times in total endoscopic coronary artery bypass grafting?Predictors, causes, and consequences of conversions in robotically enhanced totally endoscopic coronary artery bypass graft surgery.Factors influencing blood transfusion requirements in robotic totally endoscopic coronary artery bypass grafting on the arrested heart.Five hundred cases of robotic totally endoscopic coronary artery bypass grafting: predictors of success and safety.Robotic total endoscopic double-vessel coronary artery bypass grafting--state of procedure development.Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
P50
Q34486929-CA41505F-D719-4D2F-B7B9-FEFBDC7FAFE6Q36393502-A13FF229-AB4E-45E2-93B1-E8CE36E1351BQ37193530-6A48D7E5-3E69-4F60-8510-91E7AA32B098Q37324232-CD3C9873-B853-4A85-9C4A-8A3752BC1CFFQ40575191-A6C47296-58D5-48DC-B4EA-4C800858E2ACQ40886665-9F350BC4-4BD1-4B1D-A676-5423B136090BQ41932523-3EEFC845-86BB-4B1A-BC5A-335A0432D55EQ42836046-E8460B51-81FD-4A31-9521-2A770FC66CD6Q43480629-5DCE2CBA-FDBF-41AF-A4E7-65AADC8FAB19Q43680136-261D762C-D23B-4A05-AA8F-5D03E322936BQ43949691-74B85E0A-A2F1-490E-8677-B94A94A79A1EQ44286442-D50FCFEE-4397-48F2-8BAE-B74537176D57Q44395521-DE9B7F87-042E-4A8E-9C24-88BF9F4B0C99Q44864923-DBEC9F78-E2C2-4E05-8C64-DDA8E223396CQ44969558-42E8B043-A8F3-4F21-9C0F-3861046D5F47Q45160697-AC614CEF-B859-4947-9C8A-874FE2289B04Q45251204-F7F9DE4F-2BC9-49E2-91BF-F0497CF2018DQ45752860-9372FC7A-1B3C-48E5-91D5-F1BC41E0998DQ45873136-A674F1A2-387D-4B0E-A705-7DA598E68B3BQ45875793-A53A6A2D-CDDF-4318-BDBA-91B55CB9D839Q45958220-E4E14A08-B903-4920-A803-8FB360032AADQ46661155-5C19E308-6234-49CF-95EE-1CF08AB6854BQ46673359-7EF9918C-7A03-4447-B898-2E0337B1B5CFQ46772462-2BE7895E-6804-44D6-B5A2-90E1039A8397Q46843047-11645EB4-ECD1-4B22-AC29-8A865995996DQ46976004-1988DC13-B879-4FF0-B137-5AB1F79F9D91Q47311676-9F140C69-7AB8-4E3B-85B2-B52F6D1F92FBQ47354552-4DCB858D-C5D4-40BA-B7E5-F429B39B7461Q47762131-7D859042-208A-4680-9F6D-3C51D757F708Q47792245-409F47F5-97C6-4156-9C22-FA23403135D2Q47904717-859956C6-88BC-4CBD-8128-CDA5D67BB822Q48330128-86323E00-2818-4FEC-B6E2-F94057618EF4Q48891290-5267AF01-8A09-46AE-A591-7B1CBF6F001FQ49711678-E496B447-902F-4CDA-8990-593FAFD7A1F5Q50126880-32147FAF-9D6E-42E6-91D7-E5DDC768541BQ50544393-DDE959FA-5F0D-4AB6-BC46-49BBDD08E3E1Q50569188-4FBF07B5-876C-4F4E-B2FD-5684FFE9D1D7Q50765349-7D277FDE-4BA5-48FF-BBB3-91DBAB5370C3Q50779507-9D37B780-4810-45D1-A8C8-1E984FD271D6Q50894204-966772CC-D1EB-4691-AFF7-EDF4867F6437
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thomas Schachner
@ast
Thomas Schachner
@en
Thomas Schachner
@es
Thomas Schachner
@nl
Thomas Schachner
@sl
type
label
Thomas Schachner
@ast
Thomas Schachner
@en
Thomas Schachner
@es
Thomas Schachner
@nl
Thomas Schachner
@sl
prefLabel
Thomas Schachner
@ast
Thomas Schachner
@en
Thomas Schachner
@es
Thomas Schachner
@nl
Thomas Schachner
@sl
P106
P1153
6603612061
P21
P31
P496
0000-0002-5865-2787